First human tests begin for potential autoimmune disease treatment
Disease control
Recruiting now
This early-stage study aims to test the safety of a new drug called NTR-1011 in healthy adults and people with lupus or rheumatoid arthritis. Researchers will give different doses to 48 participants to see how the body handles the drug and check for side effects. The main goal is…
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC